Original Contribution | Published:

Failure of activated charcoal to reduce the release of gases produced by the colonic flora

American Journal of Gastroenterology volume 94, pages 208212 (1999) | Download Citation



Objective: Activated charcoal is used to treat excessive volume or malodor of intestinal gas. Our previous studies demonstrated that activated charcoal failed to bind appreciable quantities of the volumetrically important gut gases. However, the odor of feces and flatus derives primarily from trace quantities of sulfur-containing gases, primarily H2S and methanethiol, which should avidly bind to activated charcoal. The goal of this study was to determine if ingestion of activated charcoal reduces the fecal release of sulfur gases. Methods: Five healthy human volunteers ingested 0.52 g of activated charcoal four times daily for 1 wk and the fecal liberation of intestinal gases was measured before and after the activated charcoal treatment. In an effort to explain the in vivo results, additional in vitro studies were performed to compare the binding capacity of charcoal to the sulfur gas released by feces. Results: Ingestion of activated charcoal produced no significant reduction in the fecal release of any of the sulfur-containing gases, nor was total fecal gas release or abdominal symptoms significantly influenced. In vitro studies suggested that the failure of ingested charcoal to reduce liberation of sulfur gases probably is explained by the saturation of charcoal binding sites during passage through the gut. Conclusion: Commonly employed doses of activated charcoal do not appreciably influence the liberation of fecal gases.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Activated charcoal: Antidotal and other medical uses. Marcell Dekker: New York, 1980;124.

  2. 2.

    Bibliography of solid adsorbents The National Bureau of Standards: Washington, 1944.

  3. 3.

    , , Activated charcoal: In vivo and in vitro studies of effect on gas formation. Gastroenterol 1984;88: 620–624.

  4. 4.

    , , Efficacy of activated charcoal in reducing intestinal gas: A double-blind clinical trial. Am J Gastroenterol 1986;81: 532–535.

  5. 5.

    , Effects of orally administered activated charcoal on intestinal gas. Am J Gastroenterol 1981;75: 192–196.

  6. 6.

    , , , et al. Identification of gases responsible for the odor of human flatus and evaluation of a device purported to reduce this odor. Gut 1998;43: 100–104.

  7. 7.

    , , , et al. Fecal hydrogen sulfide production in ulcerative colitis. Am J Gastroenterol 1998;93: 83–87.

  8. 8.

    , , , et al. Sulphide impairment of substrate oxidation in rat colonocytes: A biochemical basis for ulcerative colitis?. Clin Sci 1993;85: 623–627.

  9. 9.

    , , , et al. A role for sulfate reducing bacteria in ulcerative colitis?. Gastroenterol 1990;98: A270.

  10. 10.

    , , Growth and activities of sulphate reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis. FEMS Micriobiol Ecol 1991;86: 103–112.

  11. 11.

    , , , et al. Bismuth subsalicylate markedly decreases hydrogen sulfide release in the human colon. Gastroenterology 1998;114: 923–929.

  12. 12.

    , , A comparison of symptoms with self-reported severe lactose intolerance after drinking milk or lactose-hydrolyzed milk. N Engl J Med 1995;333: 1–4.

  13. 13.

    SYSTAT for the Macintosh, version 5.2. SYSTAT: Evanston, IL, 1992.

Download references


Supported in part by research funds from the Department of Veterans Affairs and the National Institute of Diabetes and Digestive and Kidney Diseases (RO1-DK-13093).

Author information


  1. The Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota, USA

    • Fabrizis L Suarez
    • , Julie Furne
    • , John Springfield
    •  & Michael D Levitt


  1. Search for Fabrizis L Suarez in:

  2. Search for Julie Furne in:

  3. Search for John Springfield in:

  4. Search for Michael D Levitt in:

Corresponding author

Correspondence to Michael D Levitt.

About this article

Publication history




Further reading